Codex Genetics
Codex is a genomics company focuses on improving patient outcomes through digital precision medicine. By leveraging a proprietary bioinformatics architecture and a clinical trial matching platform, they aim to accelerate drug discovery and approval process. Codex is specialized in oncology, neurology and rare disease area.
Investor Base
Private investors
Impact Summary
Impact Governance
🗹 Responsible business practices benefiting stakeholders
[N/A] Mission aligned Shareholders
Impact Strategy
🗹 Impact is integral to business
🗹 Scalable solution with quantitative impact
☐ Evidence of, or opportunity to, mission lock
Impact Track Record
🗹 Demonstrable impact commitment from founder
Fundraising Details
Asset Class
Company
Targeted Amount
TBC (Series B)
Close Date
2023
Impact theme
Healthcare
Geography
GBA